BASF has signed a definitive agreement to sell its manufacturing facility in Shreveport, LA and the related contract manufacturing business for finished pharmaceuticals to Dr. Reddy’s Laboratories, headquartered in Hyderabad, India. Financial details were not disclosed.     As part of the agreement, BASF’s 150 employees will transfer to Dr. Reddy’s. The 42-acre Shreveport facility currently manufactures and packages prescription and OTC pharmaceutical products, liquids, tabl...